Tower Research Capital (TRC)’s Sionna Therapeutics SION Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$137K Buy
26,094
+24,815
+1,940% +$570K ﹤0.01% 2614
2026
Q2
$56.3K Sell
1,279
-1,073
-46% -$42.9K ﹤0.01% 2634
2026
Q1
$94.3K Buy
2,352
+1,223
+108% +$46.7K ﹤0.01% 2232
2025
Q4
$46.4K Sell
1,129
-3,361
-75% -$127K ﹤0.01% 2478
2025
Q3
$132K Buy
+4,490
New +$97.7K ﹤0.01% 1792

Other funds holding SION

Tower Research Capital (TRC)'s SION Position: Q3 2026 in Review

Tower Research Capital (TRC) increased its Sionna Therapeutics (SION) stake by 1,940% in Q3 2026, buying an estimated $570K and bringing the position to 26,094 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #2614.

Tower Research Capital (TRC) first reported a position in SION in Q3 2025 and has held it in 5 quarters since. 134 funds tracked by Wall St. Rank hold SION as of Q3 2026.

  • Tower Research Capital (TRC) held 26,094 shares of Sionna Therapeutics worth $137K as of Q3 2026.
  • Tower Research Capital (TRC) bought 24,815 Sionna Therapeutics shares in Q3 2026, an estimated $570K.
  • Sionna Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #2614 holding.
  • Tower Research Capital (TRC) first reported a position in Sionna Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • 134 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.